TRACON Pharmaceuticals Alpha and Beta Analysis
| TCONDelisted Stock | USD 1.60 0.55 52.38% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as TRACON Pharmaceuticals. It also helps investors analyze the systematic and unsystematic risks associated with investing in TRACON Pharmaceuticals over a specified time horizon. Remember, high TRACON Pharmaceuticals' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to TRACON Pharmaceuticals' market risk premium analysis include:
Beta 2.24 | Alpha (2.12) | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
TRACON |
TRACON Pharmaceuticals Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. TRACON Pharmaceuticals market risk premium is the additional return an investor will receive from holding TRACON Pharmaceuticals long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in TRACON Pharmaceuticals. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate TRACON Pharmaceuticals' performance over market.| α | -2.12 | β | 2.24 |
TRACON Pharmaceuticals Fundamentals Vs Peers
Comparing TRACON Pharmaceuticals' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze TRACON Pharmaceuticals' direct or indirect competition across all of the common fundamentals between TRACON Pharmaceuticals and the related equities. This way, we can detect undervalued stocks with similar characteristics as TRACON Pharmaceuticals or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of TRACON Pharmaceuticals' fundamental indicators could also be used in its relative valuation, which is a method of valuing TRACON Pharmaceuticals by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare TRACON Pharmaceuticals to competition |
| Fundamentals | TRACON Pharmaceuticals | Peer Average |
| Return On Equity | -12.77 | -0.31 |
| Return On Asset | -0.2 | -0.14 |
| Profit Margin | 0.14 % | (1.27) % |
| Operating Margin | (32.12) % | (5.51) % |
| Current Valuation | (2.64 M) | 16.62 B |
| Shares Outstanding | 2.68 M | 571.82 M |
| Shares Owned By Insiders | 2.20 % | 10.09 % |
TRACON Pharmaceuticals Opportunities
TRACON Pharmaceuticals Return and Market Media
The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | TRACON Pharmaceuticals Announces Reverse Stock Split | 04/08/2024 |
2 | UPDATE 1-US airlines seek FAA extension of New York minimum flight requirements cuts -letter | 04/10/2024 |
3 | Why Medical Properties Trust Shares Are Trading Higher By Around 13 Here Are 20 Stocks Moving Premarket | 04/15/2024 |
4 | Insider Trading | 05/07/2024 |
5 | TRACON Pharmaceuticals Reports First Quarter 2024 Financial Results andProvides Corporate Update | 05/14/2024 |
6 | TRACON Pharmaceuticals Inc Q1 2024 Earnings Call Transcript Highlights Strategic ... | 05/15/2024 |
7 | TRACON Announces Publication in Clinical Cancer Research of Phase 2 Clinical Data for TRC102, a DNA Damage Repair Inhibitor, in Recurrent Glioblastoma Patients | 06/11/2024 |
8 | TRACON Pharmaceuticals Downgraded to Hold at StockNews.com - Defense World | 06/28/2024 |
About TRACON Pharmaceuticals Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including TRACON or other delisted stocks. Alpha measures the amount that position in TRACON Pharmaceuticals has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
TRACON Pharmaceuticals Upcoming Company Events
As portrayed in its financial statements, the presentation of TRACON Pharmaceuticals' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, TRACON Pharmaceuticals' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of TRACON Pharmaceuticals' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of TRACON Pharmaceuticals. Please utilize our Beneish M Score to check the likelihood of TRACON Pharmaceuticals' management manipulating its earnings.
| 13th of March 2024 Upcoming Quarterly Report | View | |
| 8th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 13th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with TRACON Pharmaceuticals
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in TRACON Stock
If you are still planning to invest in TRACON Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the TRACON Pharmaceuticals' history and understand the potential risks before investing.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Stocks Directory Find actively traded stocks across global markets |